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Early detection of Autism Spectrum Disorder (ASD) has proven to be of high significance, however there 
is a limited availability of ASD screening tools in Serbian language. In this study we aim to translate, 
assess reliability and, in part, test the applicability of Modified Checklist for Autism in Toddlers, Revised, 
with Follow-Up (M-CHAT R/F) in Serbian Healthcare environment. We screened 128 children in three 
primary healthcare centres and 20 children in a tertiary psychiatric center, using M-CHAT R/F translated 
into Serbian language, between December 2014 and October 2015. At the end of the screening process 
80% of participants in the risk group screened positive for ASD, while in the control group 4 (3.1%) 
participants screened positive, with a mean total scores of 8.25 and 0.66 respectively. The Cronbach’s 
α coefficient was 0.91 and Guttman’s λ6 was 0.93. Test – retest reliability was deemed as acceptable, 
and no significant correlation was found between M-CHAT-R/F scores and Epworth Sleepiness Scale 
for children scores. The Serbian version of the M-CHAT-R/F has shown satisfactory reliability. We can 
therefore assert that it is a reliable tool for identifying ASD and it can be used in clinical practice to 
improve early detection, assessment and treatment.
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder manifested by impairments in 
social interaction and communication, as well as the presence of repetitive and restricted behaviours/interests1. 
In 2010, the prevalence of ASD in the United States was estimated at 14.7 cases per 1000 children, or 1 in 68 
children, with substantial variability in estimates by region, sex, and race/ethnicity2. Diagnosis of ASD relies 
on set of subjective qualitative or semi-qualitative criteria, however an objective clinical test that can facilitate 
diagnostic process is not available3. Furthermore, it is well established that early intervention is associated with 
better clinical outcomes in persons with ASD4, raising the hope that treatment during the initial phase of illness 
could prevent the development of more severe form of disorder and thus reduce risk of chronic symptoms and 
disability. Therefore, for ASD in particular, it is crucial to improve paediatrician skills in early screening of pos-
sible developmental delay, more specifically ASD5. The American Academy of Paediatrics (AAP) recommends 
that ASD-specific standardize screening should be performed at 18- and 24-month preventive check-ups6; even 
though a 2009 survey among paediatricians found that only 28% routinely used it and most common barriers 
included lack of time and lack of familiarity with screening tools7.
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Although autism is hard to diagnose before 36 months, symptoms often surface between 12 and 18 months8, 
there is a large delay between the first parental concerns and the diagnosis9. Recognition and diagnosis of ASD 
also depends on the parents’ education level and attitude10. While the average reported age of ASD diagnosis is 
3.9 to 5.7 years depending on research design11–13, many parents of diagnosed ASD children recall concerns in the 
years prior to ASD initial diagnosis, and as many as 50% of them suspected their children had problems even by 
the end of their first year. Not to mention, that children with milder symptoms are often diagnosed much later.
Early detection of ASD proved to be of high significance, since early implementation of intensive treatment 
strategies leads to a better prognosis for the affected child. Moreover, early detection helps with reducing family 
stress and societal burden9. Due to lack of reproducible biological markers for determination of an ASD diag-
nosis, early detection has been based on a combination of different strategies. Some of those strategies include 
developmental surveillance through expert casual assessment of communication, social and play skills, and con-
sideration of parental concerns13,14. Paediatricians need support as well, in the form of sensitive screening tools, 
in order to provide better care, and if needed, refer the child to other specialists6.
ASD-specific screening tools have been classified into level 1 and level 2 screening tools. Level 1 screening 
tools have been designed for primary health care setting6, and level 1 screening applies to all children regardless 
of risk status (i.e., “universal” screening). In contrast, level 2 screening is targeted at children already identified as 
being at increased risk (e.g., due to a positive family history, concerns raised by parents or clinicians, identifica-
tion by a level 1 screener).
One of the first available level 1 screening tools for ASD was the Checklist for Autism in Toddlers (CHAT), 
developed by Baron-Cohen et al. in 1992. As a more sensitive alternative to this questionnaire, Robins et al. con-
structed in 2001, for the needs of the American healthcare system, a Modified Checklist for Autism in Toddlers 
(M-CHAT)15. This adaptation eliminated the physician observation section and expanded on the parent report 
items. Extensive validation of this instrument pointed towards the need for a follow-up, done by phone or other 
methods, of children with positive screening, in order to minimize the number of false positive cases. As to avoid 
the false negative cases, the minimum score for a positive screening result was significantly lowered. In the mean-
time, the authors performed a revision of the questionnaire, decreasing the number and rephrasing certain items. 
Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT-R/F) was designed by Robins et al. 
in 200916,17 and it has since been translated into 35 languages or dialects.
M-CHAT-R/F is a two-stage ASD screening instrument intended for parents of 16 to 30 months old chil-
dren. It contains 20 items for which the parent choses a YES/NO answer. In case the screening proves positive 
(3 or more positive answers), a structured Follow-Up interview (FUI) is conducted with the parent, in order to 
attain additional information regarding examples of risk behaviour of the child and to determine the need for 
further diagnostics, monitoring and evaluation. For children whose scores are 8 and above, it is acceptable to 
bypass the Follow-Up and refer them immediately for diagnostic evaluation and eligibility evaluation for early 
intervention16.
Primary health care institutions in Serbia are organized in each municipality; each child is assigned a pae-
diatrician as a primary health care chosen doctor for the entire school age, and attends regular preventive 
health screening visits during early development. Paediatricians, if necessary, can refer children to secondary 
or tertiary health care levels, depending on the problem. Developmental problems in children are fully assessed 
mostly in tertiary health care institutions, most of which are specifically oriented to a particular area. In view 
of limited availability of level 1 screening tools in Serbian language, as well as sparse data of their application in 
Serbian primary health care setting, we sought to translate, assess reliability and, in part, test the applicability of 
M-CHAT-R/F as an ASD screening tool in Serbian clinical setting.
Methods
Preparation of Serbian M-CHAT/R-F version. After obtaining permission from the authors, the 
M-CHAT-R/F was translated from English to Serbian, independently by two bilingual researchers, and the trans-
lations were compared and combined. A back translation was also performed by a third party, with the result 
comparable to the original. Slight adaptation of wording was required due to languages differences. The research 
was conducted in three primary health care centres, and in one tertiary psychiatric centre with a child and ado-
lescent psychiatric unit within it, between December 2014 and October 2015.
For the purpose of the study primary heath care centres were randomly selected. The tertiary psychiatric 
centre was chosen because it is one of the institutions where children with suspected developmental problems 
are referred to for assessment and treatment, within the child and adolescent psychiatry unit. Organization of 
Serbian health care system is at present time constructed in such a way that this level of specialized health care 
service was deemed most adequate in providing us with the easiest access to children, within the Serbian health 
care system, in risk of developmental delays or disorders. The ethics committees of Institute of Mental Health in 
Belgrade and School of Medicine, University of Belgrade approved the experimental protocols used in the current 
study. All experiments were performed in accordance with the committees’ guidelines and regulations. Written 
informed consent was obtained from all participants or legal guardians. Each patient’s capacity to provide consent 
was confirmed by a family member or legal guardians when needed. Individuals with a legal measure of reduced 
capacity were excluded.
Participants. The control group was comprised of 128 participants in primary healthcare setting, some of 
which were children attending a scheduled preventive health-screening visits at 18 and 24 months of age, and 
some were children captured during a spontaneous paediatrician visit, between 16 and 30 months of age.
The risk group included 20 children, referred for evaluation and diagnostics to a specialized tertiary psychiat-
ric institution with child and adolescents psychiatry service, with suspicion of developmental delay or disorder, 
including ASD.
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Procedure. A questionnaire package was compiled, containing a written consent form, a general ques-
tionnaire covering child demographics, ASD risk factors and previous development, a Serbian version of 
M-CHAT-R/F, as well as Epworth Sleepiness Scale for children18, to assess the discriminant validity. Trained 
health care professionals administered the questionnaire packages.
The procedure included two stages. During stage one, after being provided with basic information on the 
research, the parents were asked to sign a consent form and were left to fill out the questionnaires. This usu-
ally took 20 to 30 minutes, including the 5 to 10 minutes required to complete the M-CHAT-R/F. Scoring of the 
M-CHAT-R/F was conducted on the spot.
The stage two followed in instances when the M-CHAT-R/F score was between 3 and 7. In these cases the 
Follow-up interview (FUI) was implemented, which usually took under 10 minutes. If score upon Follow-Up 
was 0–1, child has screened negative. If M-CHAT-R/F score remained at 2 or higher, the child has screened 
positive, and the attending paediatrician or child psychiatrist was notified. A number of randomly chosen par-
ticipants (N = 26) were contacted via telephone several weeks later and asked to complete again the first stage of 
M-CHAT-R/F, in order to evaluate test-retest reliability.
Results
A summary of participants’ demographic characteristics is given in Table 1.
No significant differences between groups were observed in regards to sex, age, number of siblings and par-
ents’ age at childbirth. Mean gestational age at birth was found to be lower in the risk group (F(1,136) = 9.63, 
p = 0.002), indicating a possible risk factor for onset of neurodevelopmental disturbances.
Results of screening. At stage one, in the risk group, 15 (75%) of participants were classified as high risk, 
1 (5%) as medium risk and 4 (20%) as low risk for ASD, while in the control group, 1 (0.8%) participant was 
classified as high risk, 9 (7%) as medium risk and 118 (92.2%) as low risk. Mean total score at stage one was 8.45 
(σ = 4.92) in the risk group, and 0.79 (σ = 1.49) in the control group. After the follow-up interview, in stage two, 
16 (80%) participants in the risk group screened positive for ASD, with a mean total score of 8.25 (σ = 4.88), while 
in the control group 4 (3.1%) participants screened positive, with a mean total score of 0.66 (σ = 1.37).
The frequencies of participants in both groups who scored a “fail” on each item are given in Table 2.
Participants in the risk group failed almost all items with greater frequency than participants in the control 
group. In both groups, relatively low frequencies of “fail” responses have been observed on motor items (items 4, and 
20), not surprising, considering these items were created as foils17 and do not assess ASD. A markedly high number 
of participants from the risk group failed items whose content relates to socialization (items 7, 15, and 16).
Psychometric properties. M-CHAT-R/F displayed excellent internal consistency across all items, with 
Cronbach’s α = 0.91 and Guttman’s λ 6 = 0.93 (λ 6 being based on the amount of variance in each item that can 
be accounted for the linear regression of all of the other items). Given the heterogenous content of the items, 
Cronbach’s α is suprisingly high; however, corrected item – total correlations for motor items were in the order of 
0.2, or non-significant, while corrected item – total correlations for all other items were in the range of 0.3–0.8, 
averaging at 0.67, accounting for high internal consistency.Kaiser-Meyer-Olkin (KMO) measure of sampling ade-
quacy was 0.89, which can be considered as satisfactory, given the heterogeneous content of the items. Correlation 
between total first-stage scores at the initial examination and total scores 4 weeks later was r = 0.80, p < 0.001, 
indicating acceptable test – retest reliability. No significant correlation was found between M-CHAT-R/F scores 
and Epworth Sleepiness Scale for children scores.
Discussion
This is the first study to assess reliability M-CHAT/R-F in Serbia and our paper outlines the two phases of this 
process: translation and reliability analysis. Our study suggests that M-CHAT/R-F is sufficiently reliable. Using a 
four-week test-retest method, total scores of the Serbian version of M-CHAT/R-F at two time points were signifi-
cantly correlated; measures of internal consistency were also satisfactory. Furthermore, using Epworth Sleepiness 
Scale for children we have shown that Serbian version of M-CHAT/R-F has divergent validity.
Several studies have used the M-CHAT in the general population as a level 1 screening instrument during 
well-child visits, but using the Follow-up interview reduced the screen positive rate by 65–80%19.
Some clinicians believed that M-CHAT (without FUI) is over inclusive and the later prevalence of ASD esti-
mated around 0.9% lower than the M-CHAT screen-positive rate (6.4%)20. This was a particular reason why we 
selected version with FUI and translated it into Serbian. This specific interview is a screening instrument for the 
Group
Control (N = 128) Risk (N = 20)
Sex ratio (male %: female %) 57:43 70:30
Mean age in months (standard deviation) 22.25 (3.94) 23.53 (4.26)
Mean mother’s age at childbirth (standard deviation) 30.4 (5.29) 31.2 (3.65)
Mean father’s age at childbirth (standard deviation) 33.92 (6.8) 34.47 (4.64)
Mean gestational age (weeks) at birth (standard deviation) 38.57 (2.06) 36.82 (2.87)
Number of siblings (mode) 1 1
Table 1. Sample characteristics.
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general population and it is up to the investigator, in this case predominately pediatrician, to weight the balance 
between the false negative and false positive results.
We believe that screening procedure with M-CHAT/R-F should be used in routine practice, as already is a 
standard procedure in Spain9. In USA, this instrument has demonstrated to be an effective tool for screening of 
low-risk toddlers and American Academy of Child and Adolescent Psychiatry (AACAP) supports the screening 
of ASD in young children and, in some instances, in older ones, as well21. Children should be rescreened if they 
are younger then 24 months, as recommended by American Academy of Pediatrics, and authors of the instru-
ment suggested that all children who continue to show risk after Follow-Up should be screened, and that this is 
anticipated to be approximately one third of all of the children who complete the Follow-Up based on initial risk, 
and will need referral for further diagnostic procedure and early interventions16. However, screening information 
should be carefully communicated to the parents and in addition to education on how to use the instrument, the 
pediatrician should acquire knowledge about motivational strategies for parents/caregivers to follow up diagnos-
tic and treatment procedures.
M-CHAT/R-F administration should start with the pediatrician and/or member of developmental team 
within the primary health care center. They have to introduce the characteristics of this screening instrument 
to parents. We clearly see the need for coordination between the health services and specific early intervention, 
either with health care, education or social welfare system.
Implementing standardized screening procedure can greatly decrease the time in which the children and their 
parents are referred to the centers where they can get the proper diagnostic and suggested treatment. Children 
who receive early interventions at younger ages have improved outcomes in different developmental domains 
(communication, language, and social skills)19. Also, in the creation of policies devoted to early development it 
is important to have standardized screening tools in order to be able to identify children at risk and to further 
promote developing of centers for early intervention.
Limitations
Primary limitations of our study are relatively small sample sizes, and the fact that the risk group was selected 
solely on basis of referral for diagnostic evaluation, with suspicion of ASD or developmental delay, and not on 
basis of a confirmed ASD diagnosis, which would have enabled calculating instrument sensitivity and specific-
ity on our sample. However our design corresponds fully to the fact that we conducted a naturalistic study, in a 
‘real-life’ clinical setting. To overcome these limitations follow-up research with more sophisticated design will 
be required, taking into consideration opinions and comments of mental health professionals who administrated 
the Serbian translation of M-CHAT-R/F. Finally, in the current study we did not include a group diagnosed with 
ASD in order to have a comparison group.
Conclusion
The Serbian version of the M-CHAT-R/F has shown satisfactory reliability. We can therefore assert that it is a 
reliable tool for identifying ASD and it can be used by healthcare professionals in their clinical practice to improve 




1. 3 (2.3%) 12 (60%)
2. 5 (3.9%) 7 (35%)
3. 5 (3.9%) 9 (45%)
4. 1 (0.8%) 1 (5%)
5. 11(8.6%) 5 (25%)
6. 6 (4.7%) 10 (50%)
7. 1 (3.1%) 16 (80%)
8. 3 (2.4%) 7 (35%)
9. 2 (1.6%) 10 (50%)
10. 2 (1.6%) 10 (50%)
11. 2 (1.6%) 10 (50%)
12. 1 (0.8%) 4 (20%)
13. 10 (7.8%) 6 (30%)
14. 1 (0.8%) 8 (40%)
15. 2 (1.6%) 14 (70%)
16. 9 (7%) 16 (80%)
17. 4 (3.1%) 9 (45%)
18. 3 (2.3%) 12 (60%)
19. 10 (7.8%) 9 (45%)
20. 1 (0.8%) 3 (15%)
Table 2.  Frequencies of “fail” scores per item in control and risk group. Description of items avalable online 
(http://mchatscreen.com).
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identification and consequently early intervention. Many studies already have shown that early interventions are 
associated with improved social behavior, language improvement and decrease of other ASD symptoms.
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